Etiome

Preemptive medicine for better health

[Etiome @etiome]

Being #FlagshipFounded means being part of an ecosystem of bold thinkers & fearless builders, driven by a shared ambition to shape the future of health. At Etiome, we embody this spirit as we seek to create true preemptive healthcare. Congrats @FlagshipPioneer on 25 years!

[Etiome @etiome]

We’re thrilled to welcome Sandra Engle as our new Head of Biology! Sandi brings a wealth of experience in translational science, target validation, and platform-driven discovery. Her leadership will be instrumental as we work to develop preemptive medicines for better health.

[Etiome @etiome]

At Etiome, we build and apply detailed models of how biology shifts over the course of disease based on vast amounts of patient data, revealing new insights and opportunities to slow, stop or even prevent disease. Listen: https://t.co/9m4j7hT1wS

[BioSpace @biospace]

With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.

https://t.co/4nETRyjam3

[C&EN (Chemical & Engineering News) @cenmag]

Flagship Pioneering has unveiled a new start-up that aims to find, then drug, targets that are specific to different states of diseases. The company, Etiome, will begin with metabolic, neurodegenerative, and inflammatory illnesses. https://t.co/waGJsUF7hi

[Boston Business Journal @BosBizJournal]

A new Cambridge biotech is creating a roadmap to expand preventive health to a broader range of diseases, treating patients before they become irreversibly ill. https://t.co/yKrVGa7zYw

[MedCity News @medcitynews]

Aiming for Earlier Intervention, Flagship Startup Etiome Emerges to Define ‘Biostages’ of Disease https://t.co/AkGISmvC5B

[Ben Fidler @BentheFidler]

Etiome, a new Flagship startup, looks to catch disease before it strikes https://t.co/6N9rxyHAxd by @gwendolynawu #biotech #startups @FlagshipPioneer

[Rowan Walrath @rowanwalrath]

.@FlagshipPioneer has unveiled a new start-up that aims to find, then drug, targets that are specific to different states of diseases. The company, Etiome, will begin with metabolic, neurodegenerative, and inflammatory illnesses.

https://t.co/KByYMZyuAX

[Etiome @etiome]

For Etiome, and @FlagshipPioneer , the future of preemptive medicine begins now. Learn more about us at https://t.co/maZMnxQj3Z #Biotech #PreemptiveMedicine #FlagshipFounded

[Etiome @etiome]

Introducing Etiome: developing Biostaged Medicines that halt or reverse the progression of disease before the development of damage, discomfort, or disability. Learn more: https://t.co/6UneUgo5ls

[Etiome @etiome]

Through our Temporal Biodynamics™ platform, Etiome leverages expansive data and AI to deliver unprecedented insights into disease progression, enabling the development of therapeutics that intervene at earlier stages to treat disease more effectively.